NCT06644534Phase 2Completed

A Study to Assess TTI-0102 vs Placebo in MELAS Patients

Study sponsor: Thiogenesis Therapeutics, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-01-12Actual
Enrollment · participants9Actual
Source updated2026-07-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 12 participants (planned). After: 9 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 30 Apr 2026. After: 12 Jan 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview